Publications

2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000

CERTs Publications 2004

One vehicle for disseminating the information learned from CERTs projects is through publication in peer-reviewed medical journals.

• Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, Yood MU, Morse AN, Platt R. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004;191:398-407.
• Apter AJ, Kinman JL, Bilker WB, Herlim M, Margolis DJ, Lautenbach E, Hennessy S, Strom BL. Represcription of penicillin after allergic-like events. J Allergy Clin Immunol 2004;113:764-770.
• Berlin JA, Ghersi D. Prospective meta-analysis in dentistry. J Evid Base Dent Pract 2004;4:59-64.
• Butler J, Arbogast PG, Daugherty J, Jain MK, Ray WA, Griffin MR. Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge. J Am Coll Cardiol 2004;43:2036-2043.
• Butler J, Emerman C, Peacock WF, Mathur VS, Young JB; VMAC study investigators. The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure. Nephrol Dial Transplant 2004;19:391-399.
• Califf RM. Defining the balance of risk and benefit in the era of genomics and proteomics. Health Aff (Millwood) 2004;23:77-87.
• Cooper WO, Hickson GB, Fuchs C, Arbogast PG, Ray WA. New users of antipsychotic medications among children enrolled in TennCare. Arch Pediatr Adolesc Med 2004;158:753-759.
• Cooper WO, Hickson GB, Ray WA. Prescriptions for contraindicated category X drugs in pregnancy among women enrolled in TennCare. Paediatr Perinat Epidemiol 2004;18:106-111.
• Cowper PA, DeLong ER, Whellan DJ, Allen LaPointe NM, Califf RM. Economic effects of beta-blocker therapy in patients with heart failure. Am J Med 2004;116:104-111.
• Curtis LH, Ostbye T, Sendersky V, Hutchison S, Dans PE, Wright A, Woosley RL, Schulman KA. Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med 2004;164:1621-1625.
• Curtis LH, Law AW, Anstrom KJ, Schulman KA. The insurance effect on prescription drug expenditures among the elderly: findings from the 1997 Medical Expenditure Panel Survey. Med Care 2004;42:439-446.
• Ellis JJ, Erickson SR, Stevenson JG, Bernstein SJ, Stiles RA, Fendrick AM. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med 2004;19:638-645.
• Everett WW, Zaoutis TL, Halpern SD, Strom BL, Coffin SE. Preevent vaccination against smallpox: a survey of pediatric emergency health care providers. Pediatr Infect Dis J 2004;23:332-337.
• Gould CV, Fishman NO, Nachamkin I, Lautenbach E. Chloramphenicol resistance in vancomycin-resistant enterococcal bacteremia: impact of prior fluoroquinolone use? Infect Control Hosp Epidiomol 2004;25:138-145.
• Griffin MR, Stein CM, Graham DJ, Daugherty JR, Hall K, Arbogast PG, Ray WA. High frequency of use of rofecoxib at greater than recommended doses: cause for concern Pharmacoepidemiol Drug Saf 2004;13:339-343.
• Grogan EL, Morris JA Jr, Norris PR, France DJ, Ozdas A, Stiles RA, Harris PA, Dawant BM, Speroff T. Reduced heart rate volatility: an early predictor of death in trauma patients. Ann Surg 2004;240:547-554.
• Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol 2004;57:1107-1110
• Harrold LR, Andrade SE, Eisner M, Buist AS, Go A, Vollmer WM, Chan KA, Frazier EA, Weller PF, Wechsler ME, Davis KJ, Platt R. Identification of patients with Churg Strauss Syndrome (CSS) using automated data.Pharmacoepidemiol Drug Saf 2004;13:661-667.
• Kong DF, Eisenstein EL, Sketch MH Jr, Zidar JP, Ryan TJ, Harrington RA, Newman MF, Smith PK, Mark DB, Califf RM. Economic impact of drug-eluting stents on hospital systems: a disease-state model. Am Heart J 2004;147:449-456.
• Lautenbach E, Gould CV, LaRosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO. Emergence of resistance to chloramphenicol among vancomycin-resistant enterococcal (VRE) bloodstream isolates. Int J Antimicrob Agents 2004;23:200-203.
• Lautenbach E, Strom BL, Nachamkin I, Bilker WB, Marr AM, Larosa LA, Fishman NO. Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatient and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis 2004;38:655-662.
• Lo Re V III, Gasink L, Kostman JR, Leonard D, Gross R. Natural history of low-level HIV viremia on antiretroviral therapy. AIDS Patient Care STDS 2004;18:436-442.
• Linkin DR, Fishman NO, Patel JB, Merrill JD, Lautenbach E. Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2004;25:781-783.
• MacLean CH, Saag KG, Solomon DH, Morton SC, Sampsel S, Klippel JH. Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set. Arthritis Rheum 2004;51:193-202.
• Mazor KM, Simon SR, Gurwitz JH. Communicating with patients about medical errors: a review of the literature. Arch Intern Med 2004;164:1690-1697.
• Mazor KM, Simon SR, Yood RA, Martinson BC, Gunter MJ, Reed GW, Gurwitz JH. Health plan members' views about disclosure of medical errors. Ann Intern Med 2004;140:409-418.
• Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG; Iowa Women's Health Study. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004;50:72-77.
• Metlay JP, Branas CC, Fishman NO. Hospital-reported pneumococcal susceptibility to penicillin. Emerg Infect Dis 2004;10:54-59.
• Mikuls TR, MacLean CH, Olivieri J, Patino F, Allison JJ, Farrar JT, Bilker WB, Saag KG. Quality of care indicators for gout management. Arthritis Rheum 2004;50:937-943.
• Milbrandt EB, Deppen S, Harrison PL, Shintani AK, Speroff T, Stiles RA, Truman B, Bernard GR, Dittus RS, Ely EW. Costs associated with delirium in mechanically ventilated patients. Crit Care Med 2004;32:955-962.
• Murphy JE, Forrey RA, Desiraju U. Community pharmacists' responses to drug-drug interaction alerts. Am J Health-Syst Pharm. 2004;61:1484-7.
• O'Shea JC, Kramer JM, Califf RM, Peterson ED. Part I: Identifying holes in the safety net. Am Heart J 2004;147:977-984.
• Peterson ED, Hirshfield JW Jr, Ferguson TB, Kramer JM, Califf RM, Kessler LG. Part II: Sealing holes in the safety net. Am Heart J 2004;147:985-990.
• Ray WA, Meredith S, Thapa PB, Hall K, Murray KT. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004;75:234-241.
• Ray WA, Murray KT, Meredith S, Narasimhulu S, Hall K, Stein CM. Oral erythromycin use and the risk of sudden death from cardiac causes. N Engl J Med 2004;351:1089-1096.
• Rogers SO, Ray WA, Smalley WE. A population-based study of survival among elderly persons diagnosed with colorectal cancer: does race matter if all are insured? (United States). Cancer Causes Control 2004;15:193-199.
• Saag KG, Olivieri JJ, Patino F, Mikuls TR, Allison JJ, MacLean CH. Measuring quality in arthritis care: the Arthritis Foundation's quality indicator set for analgesics. Arthritis Rheum 2004;51:337-349.
• Schmid CH, Stark PC, Berlin JA, Landais P, Lau J. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level factors. J Clin Epidemiol 2004;57:683-697.
• Wegner S, Vann JJ, Liu G, Byrns P, Cypra C, Campbell W, Stiles A. Direct cost analysis of palivizumab treatment in a cohort of at-risk children: evidence from North Carolina Medicaid Program. Pediatrics 2004;114:1612-1619.
• Yokoe DS, Coon SW, Dokholyan R, Iannuzzi MC, Jones TF, Meredith S, Moore M, Phillips L, Ray W, Schech S, Shatin D, Platt R. Pharmacy data for tuberculosis surveillance and assessment of patient management. Emerg Infect Dis 2004;10:1426-1431.